DENVER (CBS4) - There is now a Food and Drug Administration-approved, monthly injection to treat addiction to alcohol, heroin and prescription pain pills. It's called Vivitrol. They prescribe it at ...

60.5 people in Cumberland County die from drug overdoses out of every 100,000 residents. Vivitrol was introduced in 2006. Patients only have to receive Vivitrol once a month via an injection in the ...

Add Yahoo as a preferred source to see more of our stories on Google. Hal Pyzyna of Lexington was 35 when he died of an opioid overdose a little more than a month after leaving an Addiction Recovery ...

Alkermes plc (NASDAQ: ALKS) today presented positive results from a long-term study of VIVITROL® (naltrexone for extended-release injectable suspension) at the 24th Annual U.S. Psychiatric and Mental ...

Demi Lovato revealed that she is currently receiving monthly shots of a drug designed to negate the effects of opioids in an effort to curb her addiction. Vivitrol is the brand name for a drug called ...

Please provide your email address to receive an email when new articles are posted on . In the U.S. approximately 8% of people aged 12 years or older have alcohol use disorder (AUD), but a majority ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. <br>In an alert posted today, the U.S. Food and Drug ...

A medication offered to heroin abusers at the Albany County jail was shown to help prevent addicts from returning to illegal drug use, according to a study published Wednesday in the New England ...

Detroit — Carl Brune told himself he could have kicked his opioid habit that he developed as a teen all on his own. The 31-year-old Shelby Township resident spent six years “messing around trying to ...

Please provide your email address to receive an email when new articles are posted on . Injectable naltrexone showed a more favorable safety profile than its oral counterpart and other alcohol use ...

DUBLIN, Jan. 14, 2021 /PRNewswire/ -- Results from a National Institute on Drug Abuse (NIDA)-funded study evaluating the efficacy and safety of naltrexone for extended-release injectable suspension ...